Zeltiq
Allergan set to bolster ‘medical aesthetics’ unit with $2.5 billion Zeltiq deal
February 13, 2017Manufacturing and Production, Sales and Marketing Allergan, FDA, Zeltiq
Allergan, the owner of Botox, has expanded its stake in the ‘medical aesthetics’ business by acquiring Zeltiq Aesthetics. Zeltiq has …
Latest content
MedPharm appoints Jason Mieding as chief operating officer
November 8, 2026
The evidence bar impacting UK medical cannabis access
November 6, 2026
